Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 12/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28340776 | 0.85 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 | |
| SCHEMBL23829960 | 0.85 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 | |
| SCHEMBL29991209 | 0.85 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 | |
| SCHEMBL28969877 | 0.84 | CHRM2 (0.39) | — | |
| SCHEMBL28531200 | 0.84 | HDAC3 (0.42) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 | |
| SCHEMBL28655610 | 0.83 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 | |
| Hydrochloric Acid SCHEMBL25328852 | 0.82 | CA2 (0.38) | ALDH1A1 | |
| SCHEMBL14198854 | 0.82 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MEN1KMT2APAOX | |
| SCHEMBL24611784 | 0.82 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MEN1KMT2APAOX | |
| SCHEMBL28099785 | 0.81 | HDAC3 (0.40) | ALDH1A1SMN1; SMN2ACHEFAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3858385-B1 | POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF | SYNDEVRX INC (US) | 2024-09-11 | — | — | EP | disclosed |